A Mumbai-based portfolio manager who's seen 4 market crashes says:
80% of Indian investors lose money because of a single morning mistake, and almost everyone makes it.
Thread 🧵
1/ He observed this pattern across Harshad Mehta, dot-com, 2008, and COVID.
Investors who look smart on paper:
- Good salary, IT or finance job
- No EMIs, no credit card debt
- Read Morgan Housel, follow finance YouTubers
- SIPs running on autopilot
Yet they still end up with:
- Blown-up portfolios in their 30s–40s
- One bad F&O year that wipes out 5 good ones
- A demat full of Yes Bank, Vodafone Idea, Suzlon… bought "for the long term"
2/ The usual suspects were investigated
- Wrong stock picks
- Bad market timing
- Too much leverage
- Greed in small caps
None of them fully explained it.
The real problem wasn't what they were buying.
It was what they did the moment the alarm rang at 7 AM.
🚀
After 2 years using ChatGPT, I've switched to Claude and I can say it has multiplied my productivity by 10x.
Here are 10 prompts I use daily that have transformed my daily life, business and investing....it could do the same for you:
Bookmark this before you lose it🧵
1⃣ The Morning Triage
"Here's everything on my plate today: [paste list]. My north-star goal this quarter is [goal]. Sort by *compounding impact*, not urgency. Kill anything that doesn't move the needle in 6 months. Give me a 3-hour deep-work block with the top 3."
Run it before coffee. The day stops happening *to* me.
2⃣The Research Compressor
"I'm researching [topic]. Find me the 5 most cited primary sources, the 2 strongest counter-arguments, and the one assumption everyone in this field is making but never questions."
Cuts a 4-hour rabbit hole into 25 minutes. Without the bias of a single author.
For the first time in a decade, every single layer of the pharma value chain is firing at once.
APIs. CDMOs. Formulations. Innovators. All of them.
Here's what's really happening 🧵
2/ Start with the Q4 FY26 earnings. The numbers are staggering:
→ Zydus: 31.2% EBITDA margin. Highest in company history.
→ Lupin: $1.3B US revenue in FY26, up ~40% YoY. 15 straight quarters of growth.
→ Neuland Labs: Q4 revenue +135% YoY, 40.5% EBITDA margin.
→ Granules: Crossed ₹5,000 cr revenue milestone for the first time ever.
→ Mankind Pharma: ₹14,278 cr revenue, +17% YoY.
3/ This isn't just companies doing well.
The quality of growth has changed.
For 5 years (2017–2022), US generics was a bloodbath — double-digit price erosion every quarter. Indian pharma companies were running on a treadmill: growing volumes, shrinking realizations.
That floor has finally arrived.
Price erosion is now low single-digit or flat. And the product mix has decisively shifted to complex generics, biosimilars, and specialty — where margins are structurally higher.
Most investors pay 50,000/month for Bloomberg terminals.
Google Gemini does the same analysis for free.
Here are 10 Gemini prompts that turn you into a Wall Street-level stock analyst overnight:
(Pin this 📌 - you'll want it every time you research a stock)
1. Complete Equity Research Report
Tell Gemini to think like a senior equity analyst at a top investment bank.
Pick any stock: [TICKER]
Ask it to cover:
• How the company makes money
• What protects it from competition (the moat)
• Where the industry is heading
• Revenue growth, margins, and debt load
This alone replaces a $200 research report.
2. Five-Year Financial Deep Dive
Tell Gemini: "Break down the last 5 years of financials for [TICKER]."
What to ask it to include:
• Year-over-year revenue growth
• Net income trajectory
• Free cash flow trends
• Profit margins over time
• Debt and return on equity
Finish with: "Tell me if this company's fundamentals are getting stronger or weaker."